Picard Medical Inc.

03/16/2026 | Press release | Distributed by Public on 03/16/2026 14:24

Proxy Results (Form 8-K)

Item 5.07.

Submission of Matters to a Vote of Security Holders.

On March 10, 2026, Picard Medical, Inc. (the "Company") held a special meeting of stockholders virtually, via live webcast (the "Special Meeting"), in accordance with the Company's Proxy Statement filed with the SEC on February 19, 2026 (the "Proxy Statement"). As of the close of business on February 6, 2026, the record date for the Special Meeting, there were 73,701,176 shares of common stock outstanding and entitled to vote, as a single class, on the proposals described below. As of the record date, approximately 57.16% of the total shares outstanding and entitled to vote were represented in person via internet webcast or by proxy at the Special Meeting. The final voting results were as follows:

1. To adopt and approve an amendment to our Second Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of the Company's capital stock from 180,000,000 to 330,000,000, which includes an increase in the number of authorized shares of the Company's common stock from 150,000,000 to 300,000,000:
Votes For Votes Against Abstentions
41,731,889 395,329 1,851
2. To approve the issuance of additional shares of the Company's common stock in an amount exceeding 20% of the Company's outstanding shares pursuant to that certain securities purchase agreement by and among the Company, HT Investments MA LLC and High Trail Special Situations LLC, for purposes of complying with NYSE American Rule 713:
Votes For Votes Against Abstentions
41,715,455 319,789 1,509
Picard Medical Inc. published this content on March 16, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 16, 2026 at 20:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]